Artiva Biotherapeutics, Inc. Common Stock Tangible Net Worth Ratio

Latest as of September 2025: 100.0%

Artiva Biotherapeutics, Inc. Common Stock tangible net worth ratio. Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($129.22 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Artiva Biotherapeutics, Inc. Common Stoc equity growth rate to track the company's year-over-year net asset growth rate.

Tangible NW Ratio

100.0%
Tangible equity / total equity

Net Assets (Equity)

$129.22 Million
USD

Intangible Assets

$0.00
Goodwill, patents, brand value

Total Assets

$148.86 Million
USD

Tangible Net Worth Ratio of Artiva Biotherapeutics, Inc. Common Stock (2024–2024)

Tangible net worth ratio of Artiva Biotherapeutics, Inc. Common Stock from 2024 to 2024. This chart shows how Artiva Biotherapeutics, Inc. Common Stock's Tangible Net Worth Ratio has changed across 1 annual periods from 2024 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $129.22 Million with intangible assets of $0.00 USD. Check asset allocation strategy of Artiva Biotherapeutics, Inc. Common Stoc to assess the company's strategic physical and investment asset allocation.

Artiva Biotherapeutics, Inc. Common Stock Tangible Net Worth Ratio by Year (2024–2024)

Artiva Biotherapeutics, Inc. Common Stock tangible net worth ratio by year from 2024 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Artiva Biotherapeutics, Inc. Common Stock from 2024 to 2024, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Artiva Biotherapeutics, Inc. Common Stoc.

Year Tangible NW Ratio Net Assets (USD) Intangible Assets Total Assets Change (pp)
2024 100.0% $186.64 Million $0.00 $209.58 Million —
pp = percentage points